Lista de obras - Moisés García-Arencibia

17beta-Estradiol transcriptionally represses human insulin receptor gene expression causing cellular insulin resistance

artículo científico publicado en 2005

A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice

artículo científico publicado en 2010

Antioxidants can inhibit basal autophagy and enhance neurodegeneration in models of polyglutamine disease.

artículo científico publicado en 2010

Autophagy and misfolded proteins in neurodegeneration

artículo científico publicado en 2010

Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson's disease: possible involvement of different binding sites at the PPARγ receptor

artículo científico publicado en 2018

Bim inhibits autophagy by recruiting Beclin 1 to microtubules

artículo científico publicado en 2012

Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile.

artículo científico publicado en 2016

Calpain inhibition mediates autophagy-dependent protection against polyglutamine toxicity.

artículo científico publicado en 2014

Cannabinoid CB1 receptors are early downregulated followed by a further upregulation in the basal ganglia of mice with deletion of specific park genes

artículo científico publicado en 2009

Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer's disease

artículo científico publicado en 2013

Cannabinoids and Parkinson's disease.

artículo científico publicado en 2009

Cannabinoids and neuroprotection in basal ganglia disorders.

artículo científico publicado en 2007

Complex inhibitory effects of nitric oxide on autophagy

artículo científico publicado en 2011

Corrigendum to "Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile" [Pharmacol. Res. 110 (August 2016) (2016) 205-215].

artículo científico publicado en 2017

Effect of endocannabinoid signalling on cell fate: life, death, differentiation and proliferation of brain cells

artículo científico publicado en 2018

Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease

artículo científico publicado en 2006

Enhanced striatal glutamate release after the administration of rimonabant to 6-hydroxydopamine-lesioned rats

artículo científico publicado en 2008

Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties

artículo científico publicado en 2006

IGF-1 receptor antagonism inhibits autophagy

artículo científico publicado en 2013

Identification of MOAG-4/SERF as a regulator of age-related proteotoxicity.

artículo científico publicado en 2010

Identification of two functional estrogen response elements complexed with AP-1-like sites in the human insulin receptor gene promoter

artículo científico publicado en 2005

Identification of virtual signal transducers and activators of transcription response elements in the human insulin receptor gene promoter.

artículo científico publicado en 2011

Neuroprotective Properties of Standardized Extracts of Hypericum perforatum on Rotenone Model of Parkinson’s Disease ⬇️

artículo científico publicado el 1 de agosto de 2013

Outbreak and Eradication of Tropical Rat Mite (Acari: Macronyssidae) in a European Animal Facility.

artículo científico publicado en 2017

Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration

artículo científico publicado en 2009

Regulation of mammalian autophagy in physiology and pathophysiology.

scientific article published on October 2010

Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ⁹-THCV in animal models of Parkinson's disease

artículo científico publicado en 2011

Synthesis, pharmacological evaluation and docking studies of pyrrole structure-based CB2 receptor antagonists.

artículo científico publicado en 2015

Transcriptional inhibition of the human insulin receptor gene by aldosterone

artículo científico publicado en 2003

Tricyclic pyrazoles. Part 8. Synthesis, biological evaluation and modelling of tricyclic pyrazole carboxamides as potential CB2 receptor ligands with antagonist/inverse agonist properties

artículo científico publicado en 2016

Lista de obras de Moisés García-Arencibia

17beta-Estradiol transcriptionally represses human insulin receptor gene expression causing cellular insulin resistance

A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice

Antioxidants can inhibit basal autophagy and enhance neurodegeneration in models of polyglutamine disease.

Autophagy and misfolded proteins in neurodegeneration

Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson's disease: possible involvement of different binding sites at the PPARγ receptor

Bim inhibits autophagy by recruiting Beclin 1 to microtubules

Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile.

Calpain inhibition mediates autophagy-dependent protection against polyglutamine toxicity.

Cannabinoid CB1 receptors are early downregulated followed by a further upregulation in the basal ganglia of mice with deletion of specific park genes

Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer's disease

Cannabinoids and Parkinson's disease.

Cannabinoids and neuroprotection in basal ganglia disorders.

Complex inhibitory effects of nitric oxide on autophagy

Corrigendum to "Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile" [Pharmacol. Res. 110 (August 2016) (2016) 205-215].

Effect of endocannabinoid signalling on cell fate: life, death, differentiation and proliferation of brain cells

Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease

Enhanced striatal glutamate release after the administration of rimonabant to 6-hydroxydopamine-lesioned rats

Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties

IGF-1 receptor antagonism inhibits autophagy

Identification of MOAG-4/SERF as a regulator of age-related proteotoxicity.

Identification of two functional estrogen response elements complexed with AP-1-like sites in the human insulin receptor gene promoter

Identification of virtual signal transducers and activators of transcription response elements in the human insulin receptor gene promoter.

Neuroprotective Properties of Standardized Extracts of Hypericum perforatum on Rotenone Model of Parkinson’s Disease ⬇️

Outbreak and Eradication of Tropical Rat Mite (Acari: Macronyssidae) in a European Animal Facility.

Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration

Regulation of mammalian autophagy in physiology and pathophysiology.

Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ⁹-THCV in animal models of Parkinson's disease

Synthesis, pharmacological evaluation and docking studies of pyrrole structure-based CB2 receptor antagonists.

Transcriptional inhibition of the human insulin receptor gene by aldosterone

Tricyclic pyrazoles. Part 8. Synthesis, biological evaluation and modelling of tricyclic pyrazole carboxamides as potential CB2 receptor ligands with antagonist/inverse agonist properties